Fig. 3.
Fig. 3. Tc2-type donor CD8+ T cells abrogate marrow graft rejection. Host B6 (H-2b) mice were irradiated at 950 or 650 cGy; all mice received 1 × 107 TCD bone marrow cells from B6D2F1 (H-2b/d) donor mice. Engraftment control mice (950/−) and rejection control mice (650/−) received only the donor bone marrow at the time of transplant; other groups received additional donor CD8+ T cells (1 × 107cells) of Tc1-type (650/Tc1) or Tc2-type (650/Tc2). Peripheral blood lymphocytes were isolated on days 30 and 90 posttransplant and stained with H-2b FITC (common to both donor and host cells) and H-2d PE (specific for donor cells); the percentage of donor and host chimerism was then determined by flow cytometry. Each data point represents the donor chimerism result for an individual animal.

Tc2-type donor CD8+ T cells abrogate marrow graft rejection. Host B6 (H-2b) mice were irradiated at 950 or 650 cGy; all mice received 1 × 107 TCD bone marrow cells from B6D2F1 (H-2b/d) donor mice. Engraftment control mice (950/−) and rejection control mice (650/−) received only the donor bone marrow at the time of transplant; other groups received additional donor CD8+ T cells (1 × 107cells) of Tc1-type (650/Tc1) or Tc2-type (650/Tc2). Peripheral blood lymphocytes were isolated on days 30 and 90 posttransplant and stained with H-2b FITC (common to both donor and host cells) and H-2d PE (specific for donor cells); the percentage of donor and host chimerism was then determined by flow cytometry. Each data point represents the donor chimerism result for an individual animal.

Close Modal

or Create an Account

Close Modal
Close Modal